APTIMA
Device
Gen-Probe, Inc.
Total Payments
$8.9M
Transactions
31,773
Doctors
21,148
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 12,408 | 10,003 |
| 2023 | $6.6M | 8,996 | 7,020 |
| 2022 | $319,123 | 6,226 | 5,148 |
| 2021 | $172,237 | 4,099 | 3,580 |
| 2020 | $1,583 | 14 | 12 |
| 2019 | $4,567 | 4 | 3 |
| 2018 | $3,319 | 12 | 12 |
| 2017 | $1,211 | 14 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.5M | 281 | 73.1% |
| Consulting Fee | $1.3M | 241 | 14.9% |
| Food and Beverage | $800,003 | 30,646 | 9.0% |
| Travel and Lodging | $223,512 | 586 | 2.5% |
| Honoraria | $45,542 | 18 | 0.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,200 | 1 | 0.0% |
Payments by Type
Research
$6.5M
281 transactions
General
$2.4M
31,492 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10940-SC2/FluP-CSP-02 | Gen-Probe, Inc. | $4.8M | 0 |
| Year 3: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $695,716 | 0 |
| 655-A10940-001 | Gen-Probe, Inc. | $299,086 | 0 |
| 670-P10936-001 | Gen-Probe, Inc. | $195,404 | 0 |
| A10960-SC2P-CSP-01 / A10960-SC2P-CSP-02 | Gen-Probe, Inc. | $147,509 | 0 |
| 655-A10960-001 | Gen-Probe, Inc. | $109,553 | 0 |
| The association of Mycoplasma genitalium and adverse perinatal outcomes in high-risk pregnant women | Gen-Probe, Inc. | $83,347 | 0 |
| Evaluation of the Aptima CMV Quant Assay in Plasma and Non-plasma samples | Gen-Probe, Inc. | $75,000 | 0 |
| TTIMS, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $36,309 | 0 |
| Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium | Gen-Probe, Inc. | $31,053 | 0 |
| Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $19,004 | 0 |
| TTIMS - Transfusion Transmissible Infection Monitoring System, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $7,500 | 0 |
| A10810-ATVPS-CSP | Gen-Probe, Inc. | $1,800 | 0 |
Top Doctors Receiving Payments for APTIMA — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Obstetrics & Gynecology | Bayamon, PR | $348.59 | 5 |
| , M.D | Obstetrics & Gynecology | Orlando, FL | $333.43 | 7 |
| , PAC | Physician Assistant | Jamaica, NY | $323.50 | 3 |
| , MD | Obstetrics & Gynecology | Ponce, PR | $316.79 | 4 |
| , MD | Obstetrics & Gynecology | Wilmington, NC | $316.25 | 4 |
| , MD | Obstetrics & Gynecology | Saint Louis, MO | $316.25 | 4 |
| , M.D | Obstetrics & Gynecology | Cape Girardeau, MO | $316.23 | 4 |
| , M.D | Obstetrics & Gynecology | Ponce, PR | $314.22 | 3 |
| , RNP-C | Women's Health | Scottsdale, AZ | $303.42 | 3 |
| , MD | Obstetrics & Gynecology | Glendale, AZ | $303.36 | 8 |
| , MD | Gynecology | San Juan, PR | $301.89 | 5 |
| , CNM | Nurse Practitioner | Atlanta, GA | $300.44 | 3 |
| , APRN | Family | North Las Vegas, NV | $296.97 | 2 |
| , PAC | Physician Assistant | Las Vegas, NV | $296.96 | 2 |
| , APRN | Family | N Las Vegas, NV | $296.95 | 2 |
| , MD | Clinical Genetics (M.D.) | North Las Vegas, NV | $296.95 | 2 |
| , M.D | Obstetrics & Gynecology | Spring Branch, TX | $295.01 | 5 |
| , MD | Obstetrics & Gynecology | Mercedita, PR | $292.84 | 3 |
| , MD | Gynecology | Coto Laurel, PR | $288.78 | 3 |
| , APN | Family | Crown Point, IN | $288.25 | 2 |
| Carly Dearth | Family | Crown Point, IN | $288.25 | 2 |
| , FNP | Family | Chicago, IL | $288.25 | 2 |
| Diana Poortenga | Registered Nurse | Munster, IN | $288.24 | 2 |
| , NURSE PRACTITIONER | Primary Care | Calumet City, IL | $288.24 | 2 |
| , M.D | Specialist | Ponce, PR | $286.50 | 3 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $7.8M
- Hologic Sales and Service, LLC $700,808
- Hologic, LLC $188,000
- Gen-Probe Sales & Service, Inc. $75,878
- HOLOGIC INC $44,950
- Cytyc Prenatal Products Corp. $8,000
Product Information
- Type Device
- Total Payments $8.9M
- Total Doctors 21,148
- Transactions 31,773
About APTIMA
APTIMA is a device associated with $8.9M in payments to 21,148 healthcare providers, recorded across 31,773 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 12,408 transactions to 10,003 doctors.
The most common payment nature for APTIMA is "Unspecified" ($6.5M, 73.1% of total).
APTIMA is associated with 13 research studies, including "A10940-SC2/FluP-CSP-02" ($4.8M).